| Stage | MCRI | % of rev | MAR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $146M | 100.00% | $7.0B | 100.00% | MAR ×47.89 |
| Gross profit | $82M | 56.33% | $1.5B | 22.03% | MCRI +34.3pp |
| Operating income | $41M | 28.22% | $1.3B | 18.19% | MCRI +10.0pp |
| Pre-tax income | $42M | 28.79% | $1.1B | 15.13% | MCRI +13.7pp |
| Net income | $32M | 21.88% | $794M | 11.33% | MCRI +10.5pp |
| Stage | MCRI | MAR | Gap · A − B |
|---|---|---|---|
| Revenue | $146M100.00% | $7.0B100.00% | MAR ×47.89 |
| Gross profit | 56.33%$82M | 22.03%$1.5B | MCRI +34.3pp |
| Operating income | 28.22%$41M | 18.19%$1.3B | MCRI +10.0pp |
| Pre-tax income | 28.79%$42M | 15.13%$1.1B | MCRI +13.7pp |
| Net income |
| 21.88%$32M |
| 11.33%$794M |
| MCRI +10.5pp |
None
No disclosed counterparties: MCRI.